Tamio Yamaguchi

2.7k total citations
37 papers, 2.1k citations indexed

About

Tamio Yamaguchi is a scholar working on Genetics, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Tamio Yamaguchi has authored 37 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Genetics, 14 papers in Molecular Biology and 13 papers in Pathology and Forensic Medicine. Recurrent topics in Tamio Yamaguchi's work include Genetic and Kidney Cyst Diseases (34 papers), Biomedical Research and Pathophysiology (13 papers) and Renal and related cancers (11 papers). Tamio Yamaguchi is often cited by papers focused on Genetic and Kidney Cyst Diseases (34 papers), Biomedical Research and Pathophysiology (13 papers) and Renal and related cancers (11 papers). Tamio Yamaguchi collaborates with scholars based in Japan, United States and Canada. Tamio Yamaguchi's co-authors include Darren P. Wallace, Jared J. Grantham, Shizuko Nagao, Gail A. Reif, Scott J. Hempson, Benjamin D. Cowley, Franck A. Belibi, James P. Calvet, Hisahide Takahashi and Brenda S. Magenheimer and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Kidney International.

In The Last Decade

Tamio Yamaguchi

35 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tamio Yamaguchi Japan 19 1.7k 1.3k 704 363 193 37 2.1k
Brenda S. Magenheimer United States 20 1.3k 0.8× 1.2k 0.9× 521 0.7× 160 0.4× 164 0.8× 33 1.8k
Kazushige Hanaoka Japan 17 1.1k 0.6× 1.0k 0.8× 435 0.6× 186 0.5× 175 0.9× 29 1.6k
Stavroulla Xenophontos Cyprus 11 1.2k 0.7× 875 0.7× 286 0.4× 89 0.2× 94 0.5× 18 1.6k
Gail A. Reif United States 18 843 0.5× 784 0.6× 362 0.5× 213 0.6× 142 0.7× 27 1.2k
Nancy A. Benkusky United States 25 284 0.2× 888 0.7× 579 0.8× 174 0.5× 64 0.3× 37 1.6k
Ke Dong United States 19 390 0.2× 1.1k 0.8× 226 0.3× 74 0.2× 234 1.2× 31 1.4k
Anatoly Tiulpakov Russia 22 454 0.3× 637 0.5× 124 0.2× 99 0.3× 83 0.4× 131 1.5k
Martin Vollmer Germany 13 341 0.2× 1.1k 0.8× 94 0.1× 273 0.8× 257 1.3× 17 1.3k
Eva Parisi Spain 18 110 0.1× 418 0.3× 361 0.5× 255 0.7× 105 0.5× 34 1.1k
Mathias Chiano United Kingdom 15 677 0.4× 677 0.5× 136 0.2× 116 0.3× 46 0.2× 26 1.3k

Countries citing papers authored by Tamio Yamaguchi

Since Specialization
Citations

This map shows the geographic impact of Tamio Yamaguchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tamio Yamaguchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tamio Yamaguchi more than expected).

Fields of papers citing papers by Tamio Yamaguchi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tamio Yamaguchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tamio Yamaguchi. The network helps show where Tamio Yamaguchi may publish in the future.

Co-authorship network of co-authors of Tamio Yamaguchi

This figure shows the co-authorship network connecting the top 25 collaborators of Tamio Yamaguchi. A scholar is included among the top collaborators of Tamio Yamaguchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tamio Yamaguchi. Tamio Yamaguchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kato, Noritoshi, Fuminori Sato, Shoma Tsubota, et al.. (2025). Ameliorative Effect of an Anti–MicroRNA-21 Oligonucleotide on Animal and Human Models of Cystic Kidney Disease. Kidney360. 6(6). 900–913.
2.
Nagao, Shizuko & Tamio Yamaguchi. (2023). Review of the Use of Animal Models of Human Polycystic Kidney Disease for the Evaluation of Experimental Therapeutic Modalities. Journal of Clinical Medicine. 12(2). 668–668. 11 indexed citations
3.
Yoshimura, Aya, Tamio Yamaguchi, Masanori Kugita, et al.. (2021). High Levels of Dietary Lard or Sucrose May Aggravate Lysosomal Renal Injury in Non-Obese, Streptozotocin-Injected CD-1 Mice Provided Isocaloric Diets. Journal of Nutritional Science and Vitaminology. 67(4). 243–248. 4 indexed citations
4.
Bae, Kyongtae T., Aya Yoshimura, Masanori Kugita, et al.. (2021). Novel 3D capsule device to restrict kidney volume expansion on polycystic kidney progression: feasibility study in a rat model. Journal of Nephrology. 35(3). 1033–1040. 1 indexed citations
5.
Nagao, Shizuko, et al.. (2019). Increased salt intake does not worsen the progression of renal cystic disease in high water-loaded PCK rats. PLoS ONE. 14(3). e0207461–e0207461.
6.
Devassy, Jessay G., Tamio Yamaguchi, Md Monirujjaman, et al.. (2017). Distinct effects of dietary flax compared to fish oil, soy protein compared to casein, and sex on the renal oxylipin profile in models of polycystic kidney disease. Prostaglandins Leukotrienes and Essential Fatty Acids. 123. 1–13. 14 indexed citations
7.
Kugita, Masanori, Kazuhiro Nishii, Tamio Yamaguchi, et al.. (2017). Beneficial effect of combined treatment with octreotide and pasireotide in PCK rats, an orthologous model of human autosomal recessive polycystic kidney disease. PLoS ONE. 12(5). e0177934–e0177934. 14 indexed citations
8.
Devassy, Jessay G., et al.. (2014). Cyclooxygenase product inhibition with acetylsalicylic acid slows disease progression in the Han:SPRD-Cy rat model of polycystic kidney disease. Prostaglandins & Other Lipid Mediators. 116-117. 19–25. 21 indexed citations
9.
Yamaguchi, Tamio, Jessay G. Devassy, Melissa Gabbs, et al.. (2014). Dietary flax oil rich in α-linolenic acid reduces renal disease and oxylipin abnormalities, including formation of docosahexaenoic acid derived oxylipins in the CD1-pcy/pcy mouse model of nephronophthisis. Prostaglandins Leukotrienes and Essential Fatty Acids. 94. 83–89. 11 indexed citations
10.
Nagao, Shizuko & Tamio Yamaguchi. (2012). PPAR-γ Agonists in Polycystic Kidney Disease with Frequent Development of Cardiovascular Disorders. Current Molecular Pharmacology. 5(2). 292–300. 18 indexed citations
11.
Wallace, Darren P., et al.. (2008). Periostin induces proliferation of human autosomal dominant polycystic kidney cells through αV-integrin receptor. American Journal of Physiology-Renal Physiology. 295(5). F1463–F1471. 67 indexed citations
12.
Yamaguchi, Tamio, Scott J. Hempson, Gail A. Reif, Anne-Marie Hedge, & Darren P. Wallace. (2005). Calcium Restores a Normal Proliferation Phenotype in Human Polycystic Kidney Disease Epithelial Cells. Journal of the American Society of Nephrology. 17(1). 178–187. 206 indexed citations
13.
Yamaguchi, Tamio, Darren P. Wallace, Brenda S. Magenheimer, et al.. (2004). Calcium Restriction Allows cAMP Activation of the B-Raf/ERK Pathway, Switching Cells to a cAMP-dependent Growth-stimulated Phenotype. Journal of Biological Chemistry. 279(39). 40419–40430. 272 indexed citations
14.
Belibi, Franck A., Gail A. Reif, Darren P. Wallace, et al.. (2004). Cyclic AMP promotes growth and secretion in human polycystic kidney epithelial cells. Kidney International. 66(3). 964–973. 213 indexed citations
15.
Zheng, Danxia, et al.. (2003). Urinary Excretion of Monocyte Chemoattractant Protein-1 in Autosomal Dominant Polycystic Kidney Disease. Journal of the American Society of Nephrology. 14(10). 2588–2595. 102 indexed citations
16.
Nagao, Shizuko, Tamio Yamaguchi, Masatomo Kusaka, et al.. (2003). Renal activation of extracellular signal-regulated kinase in rats with autosomal-dominant polycystic kidney disease. Kidney International. 63(2). 427–437. 84 indexed citations
17.
Belibi, Franck A., et al.. (2002). The Effect of Caffeine on Renal Epithelial Cells from Patients with Autosomal Dominant Polycystic Kidney Disease. Journal of the American Society of Nephrology. 13(11). 2723–2729. 78 indexed citations
18.
Yamaguchi, Tamio, Robin L. Maser, Brenda S. Magenheimer, et al.. (2001). Polycystin-1 transforms the cAMP growth-responsive phenotype of M-1 cells. Kidney International. 60(2). 484–494. 48 indexed citations
19.
Cowley, Benjamin D., Vincent H. Gattone, Shizuko Nagao, et al.. (1997). The effect of paclitaxel on the progression of polycystic kidney disease in rodents. American Journal of Kidney Diseases. 29(3). 435–444. 17 indexed citations
20.
Aukema, Harold M., Tamio Yamaguchi, Koji Tomobe, et al.. (1995). Diet and Disease Alter Phosphoinositide Composition and Metabolism in Murine Polycystic Kidneys. Journal of Nutrition. 125(5). 1183–1191. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Brenda S. Magenheimer Breakdown of academic impact, for papers by Kazushige Hanaoka Breakdown of academic impact, for papers by Stavroulla Xenophontos Breakdown of academic impact, for papers by Gail A. Reif Breakdown of academic impact, for papers by Nancy A. Benkusky Breakdown of academic impact, for papers by Ke Dong Breakdown of academic impact, for papers by Anatoly Tiulpakov Breakdown of academic impact, for papers by Martin Vollmer Breakdown of academic impact, for papers by Eva Parisi Breakdown of academic impact, for papers by Mathias Chiano
Rankless by CCL
2026